+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Tecfidera"

From
From
From
Multiple Sclerosis Forecast and Market Analysis to 2025 - Product Thumbnail Image

Multiple Sclerosis Forecast and Market Analysis to 2025

  • Report
  • July 2018
  • 765 Pages
  • Global
From
Tecfidera - API Insight, 2022 - Product Thumbnail Image

Tecfidera - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
  • 8 Results (Page 1 of 1)
Loading Indicator

Tecfidera is a medication used to treat relapsing forms of multiple sclerosis (MS). It is a disease-modifying drug (DMD) that works by reducing the frequency and severity of MS relapses. Tecfidera is an oral medication that is taken twice daily. It is a dimethyl fumarate, which is thought to reduce inflammation in the central nervous system. It is also thought to reduce the number of white blood cells that attack the myelin sheath, which is the protective coating around nerve cells. Tecfidera is one of several DMDs used to treat MS. Other DMDs include interferon beta, glatiramer acetate, and natalizumab. These medications are used to reduce the frequency and severity of MS relapses, as well as to slow the progression of the disease. The market for Tecfidera includes companies such as Biogen, Merck, and Novartis. These companies manufacture and distribute the medication, as well as provide support services for patients taking the medication. Show Less Read more